Trial Profile
A randomised clinical study comparing the efficacy of Carbetocin versus intra-ublical Oxytocin in the treatment of retained placenta following vaginal delivery
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Mar 2017
Price :
$35
*
At a glance
- Drugs Carbetocin (Primary) ; Oxytocin
- Indications Retained placenta
- Focus Therapeutic Use
- 11 Mar 2017 New trial record